-
Targeting Brain Cancer
Researchers are trying to understand brain cancer at the molecular level. Their goal is to find new, more effective therapies for this hard-to-treat disease.
by Stephen Ornes
-
Healthy Habits
A Bacterial LinkThe microbes living in your gut may explain how diet influences colorectal cancer risk.
by Lori Miller Kase
-
Healthy Habits
Another Reason to FlossGum disease is associated with increased cancer risk.
by Kendall K. Morgan
-
Q&A
Why Fat MattersCancer epidemiologist Cornelia Ulrich discusses research that explores how fat cells and cancer cells communicate.
by Marci A. Landsmann
-
Forward Look
An Overlooked Long-Term Side EffectQ&A with Patricia Ganz on chemotherapy-related nerve damage.
by Sue Rochman
-
Study Shows Minority Participation in Clinical Trials May Be Declining
Researcher speculates that costly genetic testing may be limiting outreach to underserved communities.
by Marci A. Landsmann
-
From the Editor-in-Chief
Metabolism and CancerCan cancer's dependence on sugar help researchers find new targets to treat the disease?
by William G. Nelson, MD, PhD
-
Forward Look
Your Tax Dollars at WorkQ&A with Joseph Unger on publicly funded cancer research.
by Sue Rochman
-
Forward Look
Opportunities for PreventionInteractive maps and charts illustrate how many cancers are caused by infections worldwide.
by Sue Rochman
Cancer Talk
Most Cancer Survivors Don’t Meet Healthy Diet Goals
Despite research linking fruits and vegetables to cancer survival, many people do not change their eating habits after diagnosis.
by Darlene Dobkowski
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood TestsAbout half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon